Mechanistically, through analysis of surface proteins by mass spectrometry, the interactions between CD44-hyaluronic acid and ITGB2-ICAM-1 mediate the targeting of biomimetic vesicles to the bone marrow and leukemia cells, respectively. The gene discussed is ITGB2; the disease is leukemia.